Letter from the Chairman
Welcome to the Loyola Medicine's Department of Urology.
I am very fortunate to lead the Department of Urology at Loyola which has a rich tradition of excellence in patient care, research and postgraduate training. It is an honor to build upon this historic program, which celebrates its 100th year of quality urologic care and training. From the first chairman, Dr. Frank M. Phifer, to our most recent chairman, Dr. Robert Flanigan, a tradition of excellence persists. Special recognition goes to Dr. Robert Flanigan, who served as the Chair of the Department for 34 years. During his tenure, Dr. Flanigan established Loyola as one of the leading urologic training programs in the country. His legacy is best defined by the quality of his trainees, his leadership and research innovation, and the numerous patients who were positively impacted by his compassion and expertise. We have begun plans for Dr. Flanigan’s festschrift and career celebration in the spring of 2020.
There has been significant growth over the past 6 months with the addition of three new urologists hired for strategic roles throughout Loyola University Medical Center (LUMC) and our LUHS regional system. We welcome Dr. Michael Woods, a nationally recognized expert in the area of genitourinary oncology and clinical trial development, and Dr. Kevin McVary, an internationally recognized expert in the diagnosis and treatment of enlarged prostate, erectile dysfunction, and andrology. Dr. McVary is the Director of the new Men's Health initiative within the LUHS, and we are in the final phases of launching the first Center in the Chicagoland area affiliated with a teaching hospital and medical school. As a new faculty member myself, I have started a male genitourinary reconstruction and prosthetics fellowship program within LUHS.
The Department has had a recent surge of progress in all types of medical research including clinical, translational, basic science, and Health Services Research. The key to our recent success has been our extra- and intra-departmental collaborations. Our clinical research remains very productive as evidenced by last year’s AUA national meeting where Department faculty and residents had 32 different abstracts and presentations accepted. A total of 39 “First Author” peer reviewed manuscripts were accepted from department members. This research excellence has led to the Departmental designation as a National Center of Excellence for the latest in minimally invasive therapies for several prostate conditions including cancer and BPH.
Translational research remains very active and a high priority for the Department. Recent cutting-edge observations done by Department of Urology faculty concerning the interactions of the urinary and gut microbiome and various urology disease (male and female LUTS, erectile dysfunction, bladder cancer and prostate malignancies) leads the nation in this important emerging concept.
Loyola continues its national prominence in Health Services Research (HSR) with publications in stone disease, oncology, health disparities, urethral stricture disease, BPH, erectile dysfunction and male pelvic health. With the recent addition of Dr. Alberto Colombo, a LUC Research Associate, the Department of Urology is forming a Center for Innovation to design and develop novel medical devices in the urological space. Founded by a group of surgeons and Material Science engineers, it aims to use the experience gained in the hospital setting for creating value by targeting unmet clinical needs and turn them into useful medical devices.
The residency training program remains strong under the guidance of Dr. Thomas Turk and Dr. Kristin Baldea. We retain the protected year of research where residents are encouraged and supported to pursue hypothesis-generated ideas with faculty mentorship and guidance. The diversity of training remains amongst the best offered in the country with rotations at LUMC, the Hines VA, Gottlieb Memorial Hospital and Lurie Children's Hospital. LUMC is a level one trauma and burn center which provides our residents the experience to diagnose and manage patients with genitourinary trauma and burns in both an acute and delayed setting. The training experience at the Hines VA remains outstanding under the leadership of Dr. Jeffrey Branch and direction of Dr. Grace de los Santos and Dr. Larissa Bressler.
Led by Dr. Marcus Quek, we continue to offer the highest level of surgical care for all genitourinary malignancies. Our multidisciplinary team, which includes dedicated urologic oncologists, medical oncologists, radiation oncologists, pathologists, and nursing support, provides an individualized approach to cancer care. We employ the latest innovations in diagnostics, state-of-the art therapeutic techniques, and accessibility to clinical trials in order to provide optimal outcomes for our patients. Providers at the Cardinal Bernadin Cancer Center in Maywood and the Marjorie Weinberg Cancer Center in Melrose Park provide easy and timely access for consultations.
Dr. Gopal Gupta has been a leader in the use of magnetic resonance imaging (MRI) - ultrasound fusion guided biopsy techniques and advanced molecular imaging modalities (fluciclovine PET) for prostate cancer detection and staging. All of our fellowship-trained urologists, including Dr. Alex Gorbonos, Dr. Marcus Quek, Dr. Michael Woods, and Dr. Gopal Gupta, have extensive experience with robotic surgery with proven oncologic outcomes while preserving urinary and erectile function commensurate with high quality care.
Since the publication of the landmark study led by Dr. Flanigan identifying the role of cytoreductive nephrectomy for metastatic renal cell carcinoma, Loyola has been a center of excellence for kidney cancer. Our urologic oncologists have been at the forefront of surgical innovation, employing techniques such as robotic-assisted laparoscopic retroperitoneal enucleation for small renal masses, percutaneous cryoablation, as well as taking on the most complex locally-advanced tumors involving vascular structures and adjacent organs.
Our comprehensive multidisciplinary bladder cancer program is one of the most robust in the Midwest. Loyola is one of the few centers in the Chicagoland area offering fluorescence-enhanced (Blue Light) cystoscopy for the diagnosis and management of urothelial bladder cancer. We are also one of the highest volume centers in the area performing radical cystectomy for high risk invasive bladder cancer and we offer all forms of urinary reconstruction tailored to the individual patient. Our standardized enhanced recovery protocols and extensive experience with the disease has led to improved perioperative outcomes, reduced hospital stays, and decreased readmissions.
Loyola’s Female Pelvic Medicine & Reconstructive Surgery (FPMRS) Division, led by Dr. Elizabeth Mueller, is a joint venture between the departments of Urology and Obstetrics/Gynecology that is focused on the medical and surgical treatments of women’s pelvic floor conditions. Since it’s inception in 2000, the division has participated in numerous NIH funded research initiatives that have resulted in ground-breaking clinical trials. The FPMRS division trains future leaders in FPMRS who have completed a urology or obstetrics/gynecology residency in their American Board of Urology (ABU) and American Board of Obstetrics/Gynecology (ABOG) approved fellowship. In addition, all residents from both departments rotate on FPMRS during their residency. In collaboration with Loyola’s basic scientists from the departments of Microbiology and Immunology, the division has formed the Loyola Urinary Education & Research Collaborative that is recognized as leader in understanding the urinary microbiome and its relationship to health and disease.
In coordination with Lurie Children's Hospital the pediatric urology division provides state of the art family centered care for children and adolescents with congenital and acquired conditions of the kidneys, bladder and genitalia. We have a comprehensive voiding dysfunction program employing minimally invasive diagnostic and treatment modalities including an effective biofeedback program and Botox bladder injections for complex voiding problems. We also have an active minimally invasive program including robotic surgery for urinary tract reconstruction and endoscopic management for urinary tract stones, vesicoureteral reflux and congenital obstructions in infants. Dr. Derek Matoka and Dr. Diana Bowen lead these efforts with our newest member, Dr. Catherine Seager from Boston Children's hospital, starting in the summer of 2019.
The Department now offers genitourinary reconstruction for men with urethral stricture, previous hypospadias repair related complications, pelvic fracture related urethral injury, concealed penis, and urethral fistula. Surgical expertise is also now available for men with erectile dysfunction due to significant penile curvature or Peyronie’s disease. The Loyola Medicine Men’s Health fellowship training program is led by Drs. Ahmer Farooq, Chris Gonzalez, and Kevin McVary.
Now in its 100th year, The Loyola Department of Urology continues to provide leading patient care, urologic training, and translational research. I am optimistic for the future of the department and its potential for growth in the region. We look forward to seeing everyone in Chicago for the upcoming AUA meeting.
Chris M. Gonzalez, MD, MBA, FACS
Albert J. Jr. & Claire R. Speh Endowed Professor
Chairman, Department of Urology
Loyola University Medical Center
Loyola's Urology residents spend time at several hospitals during their training, all within close proximity of each other: Loyola University Medical Center, Edward Hines, Jr. VA Hospital, Gottlieb Memorial Hospital, Ronald McDonald Children’s Hospital, and Lurie Children's Hospital.
General Surgery (8 Months)
Hines VA Urology (4 Months)
LUMC Gold Service (4 Months)
LUMC Red Service (4 Months)
Hines VA Urology (4 Months)
Lurie Children's (4 Months)
Hines VA (4 Months)
LUMC Urology Consults (4 Months)
Ronald McDonald Children's (4 Months)
FPMRS (4 Months)
GMH Chief (4 Months)
Research (12 Months)
LUMC Gold Service Chief (4 Months)
LUMC Red Service Chief (4 Months)
Hines VA Urology Chief (4 Months)
The level of residency supervision varies across rotations and level of training. At Loyola outpatient sites, the residents see the patients prior to the attending physician. At the Edward Hines, Jr. VA Hospital the resident sees the patient independently in a clinic supervised by attending physicians.
In the operating room, the residents are supervised in all operative procedures. The complexity of the procedure, the resident's previous experience with similar procedures, and the level of training determine the level of supervision.
Complete supervision of all procedures.
Complete supervision for minor endoscopic procedures and minor open cases until the resident is judged competent, then presence in the OR for these procedures. Complete supervision for major endoscopic, major open, and laparoscopic cases.
Presence in the OR for minor endoscopic and minor open cases. Complete supervision for major endoscopic, major open and laparoscopic cases.
Presence in the OR for minor cystoscopic, minor open, and major open cases excepting renal transplantation. Complete supervision transplant, major endoscopic and laparoscopic procedures.
Presence in the OR for all cases including major cases and laparoscopic cases.
The evaluation process consists of the bi-annual faculty review by all attendings involved with the individual resident using an evaluation tool. These evaluations are reviewed with the residents twice a year by the Chairman and Program Director. Resident progress is discussed in detail for all residents at each faculty meeting (every 1-2 months). Residents are required to participate in the in-service examinations of the American Board of Urology. Although a passing score is not required for graduation, grades are used to establish promotion and academic probation.
On weeknights, a Junior Resident (PGY-1, PGY-2, or PGY-3) takes primary in-house call, followed by a guaranteed post-call day-off; a Senior Resident (PGY-4 or PGY-6) provides back-up.
On weekends, a Junior Resident (PGY-1, PGY-2, or PGY-3) takes primary home call; a Senior Resident (PGY-5 or PGY-6) provides back-up.
Selection of resident candidates is made on the basis of medical school transcripts, three letters of recommendation, and a personal on-site interview with several full-time urology faculty and residents. Candidate applications and interviews are completed in the fall and winter of the fourth year of medical school. Visits to the medical center are strongly encouraged to strengthen the candidate's position.
The Urology Residency Program at Loyola University Medical Center participates in the Electronic Residency Application Service (ERAS). Please contact your medical school Dean's office for more information.
To apply, please forward the following items to us through ERAS:
- Completed application
- Photograph of applicant
- Curriculum Vitae
- Official copy of your medical school transcript
- Dean's letter
- Three letters of recommendation
- Personal statement
- Copy of USMLE Step 1 Examination scores
Deadline for submission of completed application materials for "The Match" in January, is October 1. Applicants are not reviewed until all items are received.
Loyola University Medical Center Department of Urology participates in the AUA Residency Matching Program for Urology. Visit their website for more information and to register.
For more information about Loyola Urology, please contact:
Residency Program Coordinator